雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Changes in a Bone Resorption Marker in Patients with Postmenopausal Osteoporosis Treated with Risedronate for Two Years Junichi Takada 1 , Kenshi Imoto 1 , Kousuke Iba 2 , Shigekazu Ueno 1 , Monta Nakajima 1 , Toshihiko Yamashita 2 1Department of Orthopaedic Surgery, Chitose City Hospital 2Department of Orthopaedic Surgery, Sapporo Medical University Keyword: bisphosphonate , ビスフォスフォネート , bone resorption marker , 骨吸収マーカー , risedronate , リセドロネート pp.1315-1318
Published Date 2006/12/1
DOI https://doi.org/10.11477/mf.1408100997
  • Abstract
  • Look Inside
  • Reference

 Changes in the bone resorption marker urine NTX (typeⅠcollagen crosslinked N-telopeptide) were evaluated in 40 women with osteoporosis treated with risedronate (2.5 mg/day) for two years. NTX had markedly decreased at 3 months, and at 2 years the values in 35 of the patients were within the reference range (9.3-54.3nmolBCE/mmolCr). Risedronate decreased the bone resorption marker level in the early phase and maintained the values within the reference range for two years. In about 13% of the patients they were beyond the reference range, so that it might be took into account of calcium and vitamin D supplements in these cases.


Copyright © 2006, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1286 印刷版ISSN 0557-0433 医学書院

関連文献

もっと見る

文献を共有